Valneva

Valneva OCF Margin

The Operating Cash Flow Margin of Valneva (VLA.PA) as of Oct 8, 2026 is -30.28 %. In the previous year, Operating Cash Flow Margin was -39.64 % — a change of -23.60% (higher).

OCF Margin

-30.28 %

YoY

-23.60%

Last updated:

Operating Cash Flow Margin of Valneva is 2025 -30.28 % . Operating Cash Flow Margin of Valneva was 2024 -39.64 % . It decreases by -23.60% higher compared to the previous year.

The Valneva OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2018
14.43 EUR
Jan 1, 2019
4.38 EUR
Jan 1, 2020
124.85 EUR
Jan 1, 2021
22.09 EUR
Jan 1, 2022
-67.91 EUR
Jan 1, 2023
-131.90 EUR
Jan 1, 2024
-39.64 EUR
Jan 1, 2025
-30.28 EUR
The Valneva OCF Margin history
YEAROCF MarginYoY
-30.28 %-23.60%
-39.64 %-69.95%
-131.90 %+94.24%
-67.91 %-407.37%
22.09 %-82.30%
124.85 %+2,749.67%
4.38 %-69.63%
14.43 %+18.39%
12.18 %+76.18%
6.92 %-122.27%
-31.05 %-23.27%
-40.47 %—
Access this data via the Eulerpool API

Valneva Stock analysis

What does Valneva do? Valneva SE is a biopharmaceutical company specializing in the development, production, and marketing of vaccines for humans and animals. The company was founded in 2013 through the merger of French biotech company Vivalis and Austrian biotech company Intercell. Valneva focuses on developing vaccines for infectious diseases with a significant global burden but limited commercial demand. They work closely with governments and international organizations to improve access to their vaccines in developing countries. Valneva also has a strong presence in the animal vaccine market, producing vaccines for diseases in livestock and pets. They have developed and marketed several vaccines, including Ixiaro for Japanese encephalitis and VLA15, a vaccine candidate for Lyme disease. Overall, Valneva is an international company with an impressive pipeline of vaccine candidates and a commitment to addressing global health needs. Valneva is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valneva stock

Operating Cash Flow Margin of Valneva is -30.28 % in 2025.

Operating Cash Flow Margin of Valneva changed from -39.64 % to -30.28 %, representing a -23.60% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Valneva since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Valneva with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

Margins — Valneva

All Key Metrics — Valneva